EZZ Life Science Reports Record Quarterly Growth

EZZ Life Science Holdings Ltd. (AU:EZZ) has released an update.

EZZ Life Science Holdings Ltd. reports a stellar quarterly performance with a 111% increase in customer receipts totaling $23.6m and a 372% rise in operating cash flows to $2.04m. The genomic life science company maintains a strong cash balance of $14.5m with no debt, as it continues to expand its product line and distribution network, including partnerships with DFS and Lotte Duty Free, and marketing collaborations with the Asia Pacific Aviator Club. EZZ’s strategic growth is also reflected in its active participation in major trade events and leveraging social media influencers to boost its brand presence.

For further insights into AU:EZZ stock, check out TipRanks’ Stock Analysis page.